The data displays the distribution of the global liquid biopsy market in 2016 and a forecast for 2025, by biomarker type. It is estimated that circulating tumor cells (CTCs) will remain the biggest part of the total market with a decrease from a 56 to a 50% share within this period.
2016 | 56 | 23 | 8 | 13 |
2025 | 50 | 25 | 9 | 16 |